Cointime

Nexus

company

About

Nexus is an AI-based precision dosing algorithm that minimizes drug resistance and reduces negative side effects.

Highlights

Total Funding Amount
$100K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Seed
Last Funding Money Raised
$100K
Industries
Artificial Intelligence
Founded date
Jan 1, 1994
Operating Status
Active

Nexus is an AI-based precision dosing algorithm that minimizes drug resistance and reduces negative side effects.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$100K
Nexus has raised a total of $100K in funding over 2 rounds. Their latest funding was raised on Oct 1, 2020 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2020 Seed $100K 1 gener8tor — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nexus is funded by 1 investors. gener8tor are the most recent investors.
Investor Name Lead Investor Funding Round
gener8tor Yes Seed
Cointime
เนื้อหา
บริษัท